Search by Drug Name or NDC

    NDC 00071-0525-24 Celontin 300 mg/1 Details

    Celontin 300 mg/1

    Celontin is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Parke-Davis Div of Pfizer Inc. The primary component is METHSUXIMIDE.

    Product Information

    NDC 00071-0525
    Product ID 0071-0525_7125a267-65f7-40b7-88cb-fbfc4a750ef7
    Associated GPIs 72400020000110
    GCN Sequence Number 004553
    GCN Sequence Number Description methsuximide CAPSULE 300 MG ORAL
    HIC3 H4B
    HIC3 Description ANTICONVULSANTS
    GCN 17411
    HICL Sequence Number 001890
    HICL Sequence Number Description METHSUXIMIDE
    Brand/Generic Brand
    Proprietary Name Celontin
    Proprietary Name Suffix n/a
    Non-Proprietary Name methsuximide
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form CAPSULE
    Route ORAL
    Active Ingredient Strength 300
    Active Ingredient Units mg/1
    Substance Name METHSUXIMIDE
    Labeler Name Parke-Davis Div of Pfizer Inc
    Pharmaceutical Class Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA010596
    Listing Certified Through 2024-12-31

    Package

    NDC 00071-0525-24 (00071052524)

    NDC Package Code 0071-0525-24
    Billing NDC 00071052524
    Package 100 CAPSULE in 1 BOTTLE (0071-0525-24)
    Marketing Start Date 1957-02-08
    NDC Exclude Flag N
    Pricing Information N/A